Study the Effect of Using Levofloxacin with Azithromycin with Oseltamivir in the Treatment of Covid 19 Omicron

Authors: Ayman Esmail Hussien and Osama Allam Mandour

DOI: 10.23880/accmj-16000237

Volume 9, Issue 1

Abstract

Background: A study was conducted to investigate the use of levofloxacin, azithromycin, and oseltamivir in the treatment of COVID-19 Omicron. The results showed that this combination therapy reduced hospital stays, improved survival rates, cleared lung pathological changes faster, and reduced the need for invasive mechanical ventilation. Omicron is a highly infectious variant of the coronavirus that has caused a global surge in cases. The WHO is currently assessing the effectiveness of various medications against Omicron, including monoclonal antibody therapy and antiviral drugs. The choice of oseltamivir in this study was based on its success in managing COVID-19. Levofloxacin and azithromycin were included in the treatment protocol due to their effectiveness in treating pneumonia caused by COVID-19. Many hospitals have adopted this treatment protocol. 

Keywords: Covid 19 Omicron; Levofloxacin; Azithromycin; Oseltamivir

View PDF